SHANGHAI PHARMATECHS CO.LTD
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health 2025-10-28 17:00
WuXi AppTec Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025 Backlog for Continuing Operations Up 41.2% YoY Further Raises 2025 Full-year Guidance 2025-10-26 15:53
WuXi AppTec Implements Its First Interim Dividend Plan, Distributing RMB1.03 Billion in Cash Dividends 2025-09-22 08:00
WuXi AppTec Awarded Gold Medal by EcoVadis Sustainability Rating for Second Consecutive Year 2025-09-08 20:00
WuXi AppTec Named Constituent of the FTSE4Good Index Series for Third Consecutive Year 2025-08-06 08:00
WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities 2025-07-08 10:41
WuXi AppTec Receives MSCI ESG AAA Leader Rating 2025-07-07 20:08
WuXi AppTec Nantong Site Receives 2025 Architizer A+Award for Its Unique Blend of Technology and Humanity 2025-06-27 08:00
WuXi AppTec Earns SBTi Validation for Near-Term Emissions Reduction Targets 2025-06-18 08:00
WuXi AppTec Recognized by Extel 2025 Asia Executive Team Rankings with Top Honors 2025-06-16 20:00
WuXi AppTec Q1 2025 Revenue, Profit Resume Double Digit Growth, Revenue Up 21.0% YoY, Adjusted Non-IFRS Net Profit Up 40.0% YoY; Backlog for Continuing Operations Up 47.1% YoY 2025-04-28 17:33
WuXi AppTec Revenue and Profit Achieved Steady QoQ Growth in 2024, Meeting Full-year Guidance; Q4 Revenue and Profit Both Reached Record Highs 2025-03-17 20:19
WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI) 2025-01-13 08:00
WuXi AppTec's Commitment to Sustainability Recognized by the Dow Jones Sustainability Indices (DJSI) for the Fourth Consecutive Year 2024-12-30 20:00
WuXi AppTec Ranked #1 in Global Life Sciences Tools & Services Industry in 2024 S&P Global Corporate Sustainability Assessment 2024-11-12 08:00
WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year 2024-10-30 08:00
Despite External Challenges, WuXi AppTec Revenue and Profit Continued to Grow QoQ in the First Three Quarters of 2024; the Third Quarter Revenue Back to RMB 10+ Billion, Up 14.6% YoY Excluding COVID-19 Commercial Projects; Backlog Up 35.2% YoY 2024-10-28 19:03
Despite External Challenges, WuXi AppTec Maintained Stable Operations in First Half of 2024; Revenue and Profit of the Second Quarter Both Steadily Improved QoQ as Expected, with Revenue Up 16.0% QoQ and Adjusted Non-IFRS Net Profit Up 28.5% QoQ 2024-07-29 19:05
WuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable Operations 2024-04-29 19:00
WuXi AppTec Revenue Surpassed RMB40 Billion in 2023, and Adjusted Non-IFRS Net Profit Exceeded RMB10 Billion for the First Time 2024-03-18 20:32
1 2 3 4 5 19